Furthermore, overall survival analysis based on UALCAN revealed that high expression levels of EGFR, FLT1, PLG, EDN1, CLCN5, and ABCB1 were associated with worse survival of ccRCC patients. This evidence concerns the gene EGFR and nonpapillary renal cell carcinoma.